CYCLIC COMPOUNDS FOR USE IN TREATING RETINAL DEGENERATION

Technology
E-071-2020
Patent ID
E-071-2020-0-AU-04
Country
AU
Application Type
National Stage
Patent Status
Pending
Patent Number
 
Publication Number
 
Application Number
2021300425
IC
NEI
Date Filed
Date Issued
 
Patent PDF
 
Related Technologies
TAB-4998     Using FDA-approved Small Molecule Drug Reserpine and related compounds (especially Halofantrine) To Protect Photoreceptors In Inherited Retinal Degenerations And Age-Related Macular Degeneration